7 minutes read
Inside Scoop: The Syapse Clinical Abstraction Team
Katie Levie
August 04, 2021
03/22/2021
Can You Trust Your Real-World Data?
In my last blog post, I talked about the three key imperatives that the industry faces in realizing the full potential of real-world evidence (RWE) to impact care––promising to dig a little deeper in subsequent blog posts. So let’s start this time with the first imperative: ensuring that the underlying real-world data is capable of answering the qu…
03/04/2021
A Real World Dialogue with Dr. Leroy Hood of Institute of Systems Biology
Inaugural Real World Dialogue kicked off with industry heavyweight Dr. Leroy (Lee) Hood sharing his perspective on how real-world evidence will evolve over the years and its potential to end suffering from cancer and other health challenges.
02/05/2021
The Innovation Engine That Could: Why It is Important to Carve Out Time to Innovate
Syapse made its presence known in the precision medicine and real-world evidence space over a decade ago. In this time, the use and understanding of how real-world data can impact patient care has evolved through technology, research and policy. Staying at the forefront of this work remains critical to our growth. By being a part of the larger digi…
01/28/2021
Unlocking the Potential of Real-World Evidence to Improve Cancer Care
As we close out the first month of 2021, I find myself reflecting on 2020 and feeling inspired by what the Syapse team has been able to accomplish during a year of so many challenges and unknowns. I am incredibly proud of how we came together as an organization and remained resilient and focused on building innovative solutions, breaking down silos…
12/15/2020
The FDA’s Recent Guidance on Diversifying Clinical Trials Can Revolutionize Cancer Care for Underrepresented Minorities
Clinical research serves to grow our understanding of how to best diagnose and treat cancer. For diseases such as testicular cancer and pediatric leukemia, steady increases in survival rates continue due to advancements in clinical research; while diseases such as melanoma and chronic myeloid leukemia are revolutionizing through breakthrough clin…
11/13/2020
Reflecting on the Promise of Real-World Data, a Fireside Chat with the FDA
Please fill out the form below to view the recording. Syapse hosted its 3rd annual Precision Medicine Council to convene healthcare leaders to discuss applications for real-world insights and common challenges in delivering real-world care. As a part of the council, we invited Dr. Amy Abernethy, Principal Deputy Commissioner of the FDA, to shar…